ACST - Acasti Pharma announces 1-for-6 reverse stock split
2023-07-07 08:37:25 ET
-
Canadian biopharma company Acasti Pharma ( NASDAQ: ACST ) said on Friday that it will effect a 1-for-6 reverse stock split to increase the company's per share market price and regain compliance with Nasdaq's minimum per share bid price requirement.
-
The shares will begin trading on a reverse stock split-adjusted basis on July 10, 2023, at 12:01 a.m. ET.
-
The reverse stock split will reduce the company's number of issued and outstanding shares to ~7.4 million from ~44.6 million.
-
ACST shares were trading -7.47% pre-market on Friday.
For further details see:
Acasti Pharma announces 1-for-6 reverse stock split